CN Patent

CN112773808A — 使用莫米松和奥洛他定的组合治疗过敏性鼻炎

Assigned to Glenmark Specialty SA · Expires 2021-05-11 · 5y expired

What this patent protects

本申请涉及治疗受试者(优选人)的过敏性鼻炎的方法，通过施用莫米松或其盐和奥洛他定或其盐的组合来进行。

USPTO Abstract

本申请涉及治疗受试者(优选人)的过敏性鼻炎的方法，通过施用莫米松或其盐和奥洛他定或其盐的组合来进行。

Drugs covered by this patent

Patent Metadata

Patent number
CN112773808A
Jurisdiction
CN
Classification
—
Expires
2021-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Glenmark Specialty SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.